RecruitingNCT06938100

Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL


Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment

100 participants

Start Date

Nov 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The project aims to retrospectively and prospectively analyze a population of CADASIL patients in order to study the natural history of the disease by correlating the symptom spectrum with genetic risk and specific neuroradiological and biological markers \- Stratifying patients according to their disease risk, this could contribute to the discovery of personalized therapeutic targets.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • patients of either sex older than 18 years of age;
  • finding of a pathogenic mutation on genetic analysis of NOTCH3;
  • in the absence of unambiguous mutation, presence of characteristic deposits (GOM) within small vessels at skin biopsy

Exclusion Criteria2

  • do not meet the diagnostic criteria of CADASIL;
  • are unable to give consent for the study due to aphasic or cognitive impairment or because they are deceased at the time of enrollment and their next of kin refuse to give consent for study participation.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

Hospital Universitario de la Princesa, Madrid

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06938100


Related Trials